ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/09/13 | 1,008 | 1,045 | 994 | 1,002 | +13 | +1.3% | 1,217,500 |
2019/09/12 | 1,005 | 1,010 | 981 | 989 | -7 | -0.7% | 1,006,800 |
2019/09/11 | 1,002 | 1,025 | 970 | 996 | -9 | -0.9% | 2,106,600 |
2019/09/10 | 1,014 | 1,100 | 997 | 1,005 | ±0 | ±0% | 5,538,400 |
2019/09/09 | 1,005 | 1,005 | 1,005 | 1,005 | -300 | -23% | 41,100 |
2019/09/06 | 1,303 | 1,323 | 1,298 | 1,305 | +12 | +0.9% | 197,400 |
2019/09/05 | 1,303 | 1,308 | 1,288 | 1,293 | +9 | +0.7% | 183,700 |
2019/09/04 | 1,262 | 1,299 | 1,262 | 1,284 | +12 | +0.9% | 176,900 |
2019/09/03 | 1,300 | 1,304 | 1,272 | 1,272 | -33 | -2.5% | 274,800 |
2019/09/02 | 1,307 | 1,322 | 1,287 | 1,305 | -11 | -0.8% | 216,500 |
2019/08/30 | 1,265 | 1,321 | 1,263 | 1,316 | +54 | +4.3% | 460,000 |
2019/08/29 | 1,276 | 1,305 | 1,238 | 1,262 | -10 | -0.8% | 399,400 |
2019/08/28 | 1,320 | 1,322 | 1,265 | 1,272 | -59 | -4.4% | 379,700 |
2019/08/27 | 1,380 | 1,381 | 1,331 | 1,331 | -26 | -1.9% | 285,000 |
2019/08/26 | 1,372 | 1,404 | 1,345 | 1,357 | -70 | -4.9% | 397,500 |
2019/08/23 | 1,415 | 1,435 | 1,401 | 1,427 | ±0 | ±0% | 213,800 |
2019/08/22 | 1,432 | 1,440 | 1,409 | 1,427 | +25 | +1.8% | 351,200 |
2019/08/21 | 1,406 | 1,448 | 1,395 | 1,402 | +3 | +0.2% | 430,200 |
2019/08/20 | 1,317 | 1,403 | 1,307 | 1,399 | +86 | +6.5% | 753,400 |
2019/08/19 | 1,306 | 1,316 | 1,286 | 1,313 | +5 | +0.4% | 303,000 |
2019/08/16 | 1,279 | 1,309 | 1,270 | 1,308 | +21 | +1.6% | 591,300 |
2019/08/15 | 1,251 | 1,318 | 1,241 | 1,287 | -11 | -0.8% | 361,000 |
2019/08/14 | 1,320 | 1,341 | 1,272 | 1,298 | -17 | -1.3% | 398,700 |
2019/08/13 | 1,218 | 1,340 | 1,212 | 1,315 | +71 | +5.7% | 575,700 |
2019/08/09 | 1,254 | 1,274 | 1,240 | 1,244 | -8 | -0.6% | 253,900 |
2019/08/08 | 1,240 | 1,256 | 1,206 | 1,252 | +15 | +1.2% | 271,600 |
2019/08/07 | 1,278 | 1,293 | 1,237 | 1,237 | -11 | -0.9% | 324,200 |
2019/08/06 | 1,220 | 1,272 | 1,218 | 1,248 | -55 | -4.2% | 546,100 |
2019/08/05 | 1,362 | 1,371 | 1,260 | 1,303 | -73 | -5.3% | 860,300 |
2019/08/02 | 1,395 | 1,402 | 1,376 | 1,376 | -40 | -2.8% | 258,300 |
2019/08/01 | 1,392 | 1,417 | 1,379 | 1,416 | +16 | +1.1% | 197,100 |
2019/07/31 | 1,399 | 1,406 | 1,388 | 1,400 | -5 | -0.4% | 112,500 |
2019/07/30 | 1,399 | 1,407 | 1,390 | 1,405 | +6 | +0.4% | 142,700 |
2019/07/29 | 1,423 | 1,423 | 1,395 | 1,399 | -6 | -0.4% | 135,600 |
2019/07/26 | 1,403 | 1,423 | 1,400 | 1,405 | -12 | -0.8% | 134,600 |
2019/07/25 | 1,406 | 1,421 | 1,398 | 1,417 | +4 | +0.3% | 186,300 |
2019/07/24 | 1,450 | 1,459 | 1,410 | 1,413 | -20 | -1.4% | 386,600 |
2019/07/23 | 1,420 | 1,433 | 1,407 | 1,433 | +11 | +0.8% | 139,900 |
2019/07/22 | 1,436 | 1,441 | 1,415 | 1,422 | -27 | -1.9% | 215,500 |
2019/07/19 | 1,403 | 1,457 | 1,400 | 1,449 | +53 | +3.8% | 405,600 |
2019/07/18 | 1,439 | 1,440 | 1,381 | 1,396 | -55 | -3.8% | 443,600 |
2019/07/17 | 1,476 | 1,481 | 1,431 | 1,451 | -29 | -2% | 344,500 |
2019/07/16 | 1,472 | 1,481 | 1,454 | 1,480 | +28 | +1.9% | 366,400 |
2019/07/12 | 1,495 | 1,499 | 1,451 | 1,452 | -47 | -3.1% | 347,200 |
2019/07/11 | 1,498 | 1,510 | 1,482 | 1,499 | +12 | +0.8% | 291,700 |
2019/07/10 | 1,470 | 1,515 | 1,462 | 1,487 | +27 | +1.8% | 575,400 |
2019/07/09 | 1,458 | 1,470 | 1,435 | 1,460 | +3 | +0.2% | 320,200 |
2019/07/08 | 1,490 | 1,505 | 1,446 | 1,457 | -30 | -2% | 514,800 |
2019/07/05 | 1,439 | 1,489 | 1,435 | 1,487 | +46 | +3.2% | 514,100 |
2019/07/04 | 1,435 | 1,446 | 1,408 | 1,441 | +17 | +1.2% | 419,700 |
1451~
1500
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
Chordia | 18,000円 | - | - | 0.00% | - | 3.83倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
セルソース | 62,300円 | - | - | 0.80% | 48.41倍 | 2.09倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム